Cargando…

Suspending methotrexate for 2 weeks after COVID-19 vaccination

Detalles Bibliográficos
Autores principales:	Coates, Laura C, Abhishek, Abhishek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467517/ https://www.ncbi.nlm.nih.gov/pubmed/36118533 http://dx.doi.org/10.1016/S2665-9913(22)00265-X

Ejemplares similares

Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off Methotrexate (VROOM) study)
por: Abhishek, Abhishek, et al.
Publicado: (2022)

Improving COVID-19 vaccine immunogenicity by interrupting methotrexate treatment
por: Sparks, Jeffrey A, et al.
Publicado: (2022)

Impact of methotrexate on first-dose COVID-19 mRNA vaccination
por: Connolly, Caoilfhionn M, et al.
Publicado: (2021)

Influenza vaccination and interruption of methotrexate in adult patients in the COVID-19 era: an ongoing dilemma
por: Mehta, Puja, et al.
Publicado: (2021)

Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease
por: Haberman, Rebecca H, et al.
Publicado: (2022)

The impact of COVID-19 on care of early inflammatory arthritis in the UK
por: MacPhie, Elizabeth, et al.
Publicado: (2022)

Immunity after COVID-19 vaccinations in immunocompromised patients with psoriasis
por: Boekel, Laura
Publicado: (2022)

Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster
por: Hung, Ivan F N, et al.
Publicado: (2021)

Myopericarditis after COVID-19 vaccination: unexpected but not unprecedented
por: Ryan, Margaret, et al.
Publicado: (2022)

Flare of rheumatoid arthritis after COVID-19 vaccination
por: Terracina, Katherine A, et al.
Publicado: (2021)

Adverse events after first COVID-19 vaccination in patients with autoimmune diseases
por: Boekel, Laura, et al.
Publicado: (2021)

Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial
por: Abhishek, Abhishek, et al.
Publicado: (2022)

Convalescent plasma from people vaccinated after COVID-19 infection
por: Jabal, Kamal Abu, et al.
Publicado: (2021)

Incentives for COVID-19 vaccination
por: Brewer, Noel T., et al.
Publicado: (2022)

Hospital admissions due to COVID-19 in Scotland after one dose of vaccine
por: Dean, Natalie
Publicado: (2021)

Adult-onset Still's disease after mRNA COVID-19 vaccine
por: Magliulo, Daniel, et al.
Publicado: (2021)

COVID-19 vaccine hesitancy
por: Dubé, Eve, et al.
Publicado: (2022)

COVID-19 vaccinations for children
por: Mariatulqabtiah, Abdul Razak, et al.
Publicado: (2022)

Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms
por: Heymans, Stephane, et al.
Publicado: (2021)

COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England
por: Kirsebom, Freja C M, et al.
Publicado: (2022)

COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
por: Putman, Michael, et al.
Publicado: (2022)

Perspective of patients with autoimmune diseases on COVID-19 vaccination
por: Boekel, Laura, et al.
Publicado: (2021)

Modelling vaccination strategies for COVID-19
por: Wagner, Caroline E., et al.
Publicado: (2022)

Waning effectiveness of COVID-19 vaccines
por: Chemaitelly, Hiam, et al.
Publicado: (2022)

Expecting the unexpected with COVID-19 vaccines
por: Bar-Zeev, Naor, et al.
Publicado: (2021)

COVID-19 vaccines and kidney disease
por: Windpessl, Martin, et al.
Publicado: (2021)

Are COVID-19 vaccines safe in pregnancy?
por: Male, Victoria
Publicado: (2021)

Vaccine Verification in the COVID-19 World
por: Salmon, Daniel A., et al.
Publicado: (2021)

COVID-19 vaccines in patients with cancer
por: Trapani, Dario, et al.
Publicado: (2021)

COVID-19 vaccines and women's security
por: Harman, Sophie, et al.
Publicado: (2021)

Is the attenuated humoral response to COVID-19 vaccination in anti-TNF users relevant?
por: Chhibba, Tarun, et al.
Publicado: (2022)

Adult-onset Still's disease following COVID-19 vaccination
por: Leone, Flavia, et al.
Publicado: (2021)

Long-term Benefits of Risk Factor Reduction in Takotsubo Cardiomyopathy.—A Comment on Khalighi et al. Entitled “Takotsubo Cardiomyopathy: A Long Term Follow-up Shows Benefit with Risk Factor Reduction”, J. Cardiovasc. Dev. Dis., 2015, 2, 273–281.
por: Ponamgi, Shiva P., et al.
Publicado: (2016)

COVID-19 vaccine results might inform malaria vaccine strategies
por: Abeywickrema, Movin, et al.
Publicado: (2022)

COVID-19, vaccine hesitancy and child vaccination: Challenges from Brazil
por: Fernandez, Michelle, et al.
Publicado: (2022)

Redirected vaccine imprinting by co-administration of COVID-19 and influenza vaccines
por: Boyton, Rosemary J., et al.
Publicado: (2023)

Encouraging results from phase 1/2 COVID-19 vaccine trials
por: Bar-Zeev, Naor, et al.
Publicado: (2020)

Hospitalisation among vaccine breakthrough COVID-19 infections
por: Juthani, Prerak V, et al.
Publicado: (2021)

Erythrodermic psoriasis after COVID-19 vaccination
por: Trepanowski, Nicole, et al.
Publicado: (2022)

COVID-19 vaccines in the age of the delta variant
por: Wheatley, Adam K, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8c3qokjos3h5etpl3dtne60l25